Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-25
2009-08-11
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S111000, C546S184000, C546S192000, C546S210000, C546S268100, C548S950000, C514S231200, C514S231500, C514S315000, C514S326000
Reexamination Certificate
active
07572792
ABSTRACT:
The present invention is directed to azetidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
REFERENCES:
patent: 6649603 (2003-11-01), Sum et al.
patent: 2003/0060627 (2003-03-01), Ferrer et al.
patent: 2005/0043290 (2005-02-01), Cumming et al.
patent: 2006/0276655 (2006-12-01), Blackaby et al.
patent: 2007/0105902 (2007-05-01), Lindsley et al.
patent: 2007/0249606 (2007-10-01), Lindsley et al.
patent: 2007/0254880 (2007-11-01), Blackaby et al.
patent: 2008/0090796 (2008-04-01), Blackaby et al.
patent: 2008/0108663 (2008-05-01), Lindsley et al.
patent: WO 01/77073 (2001-10-01), None
Copending U.S. Appl. No. 11/922,074, filed Jun. 13, 2006, U.S. National Stage Entry of PCT/GB06/002156, published as WO 2006/134341.
Copending U.S. Appl. No. 11/991,727, filed Sep. 25, 2006, U.S. National Stage Entry of PCT/GB06/036989, published as WO 2007/041025.
Copending U.S. Appl. No. 12/084,027, filed Oct. 27, 2006, U.S. National Stage Entry of PCT/GB06/041699, published as WO 2007/053400.
Copending U.S. Appl. No. 12/085,340, filed Nov. 23, 2006, U.S. National Stage Entry of PCT/GB06/050411, published as WO 2007/060484.
Toro, I., et al., “Development and validation of a capilllary electrophoresis method with ultraviolet detection for the determination of the related substances in a phramaceutical compound,” Journal of Chromatography A, vol. 1043(2), pp. 303-315 (Jul. 2004).
Hallett David
Lindsley Craig W
Wolkenberg Scott E.
Krovatin William
Merck & Co. , Inc.
Merck Sharp & Dohme Limited
Shameem Golam M
Yuro Raynard
LandOfFree
Azetidine glycine transporter inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azetidine glycine transporter inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidine glycine transporter inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078830